PHDS is preparing the application of imported drugs to SFDA for a new series of antibiotics of YUNGJIN PHARM.Co. LTD, Korea. The material translation, selection and edit of “Yungjin Imipenem-Cilastatin injection.500mg” has been completed, and its registration as imported drug to SFDA is in process. PHDS is also preparing the registration documentation for other two products: “Yungjin Cefotiom injection. 1g” and “Yungjin Ceftizoxime injection. 1g”. We are expecting to get their product into China soon.